"The pathway is a statement of consensus based on current evidence and accepted approaches to the management of head and neck cancer. Recommendations should be followed subject to the health professional's independent medical judgment and the patient's preference in each individual case. It should be noted that not all patients will progress through each step of the pathway. This is a consequence of many factors, including disease outcomes, management decisions and patient decisions. The requirements and recommendations outlined in this pathway relate predominately to squamous cell carcinomas (SCC) of the larynx, oral cavity, oropharynx and hypopharynx, as these are the tumour sites with the highest incidences. The pathway document has several appendices which summarise the pathology of the rare tumours of the skull base, nasopharynx, paranasal sinus, salivary glands, and thyroid."--From Executive Summary.
"This clinical cancer pathway was developed by the Head and Neck Cancer Working Group under the auspices of the Statewide Cancer Clinical Network. The project was funded by CanNET SA. CanNET is a Cancer Australia initiative, funded by the Australian Government."--Title page verso.
2 leaves of diagrams inserted.
Includes bibliographical references (pages 136-142)
In order to set up a list of libraries that you have access to,
you must first login
or sign up.
Then set up a personal list of libraries from your profile page by
clicking on your user name at the top right of any screen.